Endometrium in focus of the gynecologist’s attention: the role of hysteroscopy and immunohistochemistry in the diagnosis of chronic endometritis, the choice of treatment
DOI:
https://doi.org/10.18370/2309-4117.2017.34.24-27Keywords:
chronic endometritis, infertility, hysteroscopy, CD138, EpigalinAbstract
The aim of the study was to evaluate the immunohistochemical marker CD138 for the diagnosis of chronic endometritis in women with infertility and to explore the impact and effectiveness of Epigalin® (indole-3-carbinol – 200 mg, epigallocatechin-3-gallate – 45 mg) on the state of the endometrium based on established key relationships between structural and functional state of the endometrium, morphological and imunoglobulin features.
Materials and methods: the study included 46 women of reproductive age with infertility, ranging in age from 20 to 45 years. All women were carried out hysteroscopy with endometrial biopsy with subsequent morphological study of the endometrium and determination CD138 expression (membrane protein used as a marker of plasma cells).
Patients were randomized into two equal groups. The first group received traditional antibiotic therapy, women of the second group in combination with antibacterial therapy received Epigalin® 1 capsule twice a day for 3 months.
Monitoring the effectiveness of therapeutic interventions was carried out through 3 months after treatment conducted. Repeated CD138 expression was determined in endometrial samples obtained during Pipelle biopsy of the endometrium, which was carried out on 7–10 days of ovarian menstrual cycle. An important criterion of treatment effectiveness was the positive dynamics in the implementation of reproductive function.
Results: during a year the number of achieved pregnancies among women of the Epigalin® group was significantly higher than the other group number.
Conclusion: the comprehensive therapy with Epigalin® of chronic endometritis in women with infertility allowes tosignificantly reduce the severity of clinical symptoms, increase reproductive function, normalize morphological function and proliferation and apoptosis processes in the endometrium.
References
- Hyun Jong Park, You Shin Kim, Tae Ki Yoon, Woo Sik Lee. “Chronic endometritis and infertility. ” Clin Exp Reprod Med 43.4 (2016): 185–92.
- Chen, Y.Q., Fang, R.L., Luo, Y.N., Luo, C.Q. “Analysis of the diagnostic value of CD138 for chronic endometritis, the risk factors for the pathogenesis of chronic endometritis and the effect of chronic endometritis on pregnancy: a cohort study.” BMC Womens Health 16.1 (2016): 60.
- Kushnir, V.A., Solouki, S., Sarig-Meth, T., et al. “Systemic Inflammation and Autoimmunity in Women with Chronic Endometritis.” Am J Reprod Immunol 5.6 (2016): 672–7.
- Troedsson, M.H., Woodward, E.M. “Our current understanding of the pathophysiology of equine endometritis with an emphasis on breeding-induced endometritis.” Reprod Biol 16.1 (2016): 8–12.
- Smit, J.G., Kasius, J.C., Eijkemans, M.J., et al. “Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial.Randomized controlled trial.” Lancet 387.10038 (2016): 2622–9.
- Bouet, P.E., El, H.H., Monceau, E., et al. “Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis.” Fertil Steril 105.1 (2016): 106–10.
- Gyulmamedova, I.D. “The results of the practical application of the therapeutic and diagnostic complex for optimizing the receptivity of the endometrium to embryo implantation.” Medical and social problems of the family 17.2 (2012): 17–20.
- Boris, E.N., Suslikova, L.V., Kaminskiy, V.V., et al. “Optimization of the preparation of the morphofunctional structure of the endometrium in the programs of assisted reproductive technologies.” Reproductive endocrinology 1 (2015): 60–3. Р
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 І. Т. Кишакевич, Н. В. Коцабин, В. В. Радченко
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.